
|Articles|March 18, 2008
GPhA opposes H.R. 5629, biologics bill
Generic Pharmaceutical Association issues statement on H.R. 5629 biologics bill
Advertisement
Generic Pharmaceutical Association President/CEO Kathleen Jaeger issued a statement on the introduction this week of H.R. 5629, the "Pathway to Biosimilars Act." The
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Naloxone Sales Highlight Limited OTC Use, Access Challenges
2
Pharmacists Shifting from Reactive to Proactive Diabetes Counselors
3
Investigators Evaluate Decline in Percentage of Patients With COPD Using Inhaled Corticosteroids
4
Is it Safe for Birth Control Users to Go Years Without a Period?
5




















































































































































